Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
ObjectivesBlinatumomab was shown to be safe and effective for consolidation therapy in B-cell acute lymphoblastic leukemia (B-ALL). This study aimed to investigate the effectiveness and safety of blinatumomab in pediatric B-ALL patients in a real-world setting.MethodsThis was a retrospective, observ...
Main Authors: | Ying Wu, Yanming Li, Jia Fan, Peijing Qi, Wei Lin, Jie Yang, Huiqing Liu, Xiaoling Wang, Huyong Zheng, Tianyou Wang, Ruidong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.1034373/full |
Similar Items
-
Corrigendum: Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
by: Ying Wu, et al.
Published: (2022-12-01) -
All about blinatumomab: the bispecific T cell engager immunotherapy for B cell acute lymphoblastic leukemia
by: Reza Mirfakhraie, et al.
Published: (2024-04-01) -
The effectiveness of blinatumomab in clearing measurable residual disease in pediatric B‐cell acute lymphoblastic leukemia patients detected by next‐generation sequencing
by: Min'er Gu, et al.
Published: (2023-12-01) -
Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
by: Sandrine Niyongere, et al.
Published: (2020-06-01) -
Recent advances on blinatumomab for acute lymphoblastic leukemia
by: Juanjuan Zhao, et al.
Published: (2019-11-01)